HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles.

Abstract
Current treatment of advanced-stage nasopharyngeal carcinoma (NPC) is not satisfactory. Targeted therapies offer hope for extending survival. Here, we developed simple, robust, and NPC-specific therapeutic lipid nanoparticles based on a fusion peptide, α-NTP, made up of an amphipathic α-helical peptide (α-peptide) linked to an NPC-specific therapeutic peptide (NTP). We found that α-NTP not only retained the sub-30 nm nanostructure-controlling ability of the α-peptide but also displayed the enhanced NPC-targeting ability of the NTP, in which the α-peptide accelerated the uptake of the NTP by NPC cells, with a 4.8-fold increase. Following uptake, α-NTP-based lipid nanoparticles (α-NTP-LNs) exerted coordinated cytotoxicity by inducing cell death via apoptosis and autophagy. In vivo and ex vivo optical imaging data showed that systemically administered α-NTP-LNs efficiently accumulated in the NPC xenograft tumor and displayed high contrast between tumor and normal tissues, which was further confirmed by flow cytometry that there had been a 13-fold uptake difference between tumor cells and hepatocytes. More importantly, the therapeutic efficacy of α-NTP-LNs was specific to NPC xenograft formed with 5-8F cells but not to fibrosarcoma xenograft formed with HT1080 cells in vivo. The growth of 5-8F tumors was significantly inhibited by α-NTP-LNs, with more than 85% inhibition relative to control groups (e.g., α-NTP and PBS treatment). In a lung metastasis model of NPC, survival was significantly improved by α-NTP-LN treatment. In a word, these excellent properties of α-NTP-LNs worked in sync and synergistically, maximizing the therapeutic efficacy of α-NTP-LNs against NPC and its metastasis.
AuthorsHaiming Luo, Lisen Lu, Fei Yang, Liang Wang, Xiaoquan Yang, Qingming Luo, Zhihong Zhang
JournalACS nano (ACS Nano) Vol. 8 Issue 5 Pg. 4334-47 (May 27 2014) ISSN: 1936-086X [Electronic] United States
PMID24766601 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Drug Carriers
  • Lipids
  • Peptides
  • Recombinant Fusion Proteins
Topics
  • Animals
  • Apoptosis
  • Autophagy
  • Carcinoma
  • Cell Line, Tumor
  • Circular Dichroism
  • Contrast Media (chemistry)
  • Drug Carriers
  • Flow Cytometry
  • Humans
  • Lipids (chemistry)
  • Mice
  • Microscopy, Confocal
  • Microscopy, Electron, Transmission
  • Nanoparticles (chemistry)
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms (drug therapy)
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Peptides (chemistry)
  • Recombinant Fusion Proteins (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: